Navigation Links
Mayo Clinic study: Ossur's collars superior in immobilization and reduction of pressure
Date:12/12/2007

December 12, 2007 (Aliso Viejo, California) Ossur, an emerging leader in the non-invasive orthopaedics market following several acquisitions and a period of integration, is pleased to announce that the Journal of Trauma has published the long-awaited results of a two year cervical collar study performed by the Mayo Clinic. The study, Range-of-Motion Restriction and Craniofacial Tissue Interface Pressure from Four Cervical Collars, finds that Ossurs products the Miami J and Philadelphia collars - are superior in immobilization and the reduction of pressure, the two most critical factors in determining product for successful trauma patient outcomes.

The Study:

The Mayo Clinic study addressed the ongoing concern that occipital pressure ulcers are well-known complications for trauma patients wearing cervical collars, and assessed the effects of four commercial cervical collars: Aspen, Philadelphia, Miami J, and Miami J with Occian back on cervical range motion (CROM) and mandibular and occipital tissue-interface pressure (TIP).

Background:

Cervical spine immobilization in major trauma patients is routinely carried out to minimize the potential of secondary spinal cord injury. Although cervical injury is detected in only 5 to 10% of unconscious blunt trauma patients, the objective of preventing serious neurological injury necessitates the initiation of spinal precautions in all such patients before cervical spine clearance. Failure to achieve early spinal clearance predisposes the patient to increased morbidity secondary to extended immobilization. Trauma represents 11.4% of non-pediatric and non-maternity hospital admissions. Importantly, restrictive collars are the root causes of skin breakdown in the trauma population. As pressure-ulcers are among the most common, yet serious and costly, complications of routine spinal immobilization, these findings are significant, and factors to be considered when determining the appropriate collar for a patient. It is estimated that pressure ulcers cost $20,000US per incident.

Study Findings:

While all collars significantly restricted CROM in all planes, the Philadelphia and the Miami J were found to be the most restrictive. The Aspen collar was the least restrictive for flexion and rotation. The Miami J and the Miami J/Occian back had the lowest levels of mandibular and occipital pressure. The studys conclusions state that Ossurs collars may markedly reduce the risk of occipital pressure ulcers without compromising immobilization.


'/>"/>

Contact: Beverly Millson
beverly@missingsock.com
310-399-7599
Ossur
Source:Eurekalert

Related biology news :

1. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
2. Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients
3. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
4. Cleveland Clinic leading clinical program to improve early-stage lung cancer detection
5. Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design
6. Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong
7. Mutant sperm guide clinicians to new diseases
8. Study of African traditional medicine will begin world-first clinical trial
9. Study: diabetic neuropathy costs billions per year in lost work time
10. Study: Fountain of youth for your heart?
11. First-ever study: lack of critical lubricant causes wear in joints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... AWRE ), a leading supplier of biometrics software ... year ended December 31, 2016. Revenue for ... $6.9 million in the same quarter last year. Operating income ... to $2.6 million in the fourth quarter of 2015. Net ... or $0.02 per diluted share, which compares to $1.8 million, ...
(Date:2/8/2017)... Report Highlights The global biosurgery market should ... 2016 at a compound annual growth rate (CAGR) of ... An overview of the global market for biosurgery. - ... and 2016, and projections of compound annual growth rates ... the basis of product type, source, application, and region. ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... February 27, 2017 A Europe-wide survey of ... researchers using animals in their research treat them with due care. ... and detailed analysis of the results indicates that there is a ... to put into practice the principles of the 3Rs (Refine, ... What ...
(Date:2/27/2017)... Feb. 27, 2017 AcelRx Pharmaceuticals, Inc. ... the development and commercialization of innovative therapies for ... the U.S. Food and Drug Administration (FDA) has ... section 505(b)(2) for DSUVIA™ (formerly ARX-04) (sufentanil sublingual ... with moderate-to-severe acute pain in a medically supervised ...
(Date:2/27/2017)... and HAMILTON, Bermuda ... (NASDAQ: ADXS ) and ... companies focused on developing cancer immunotherapies, today announced ... develop a novel cancer immunotherapy agent using Advaxis, ... SELLAS, patented WT1 targeted heteroclitic peptide antigen mixture ...
(Date:2/27/2017)... ... February 27, 2017 , ... In starting a program to hire ... grandfather, “Hire for attitude. Train for skill.” , In keeping with this philosophy, the ... as a salesman. Zamzow is hoping to replicate the practice throughout the company. , ...
Breaking Biology Technology: